The mammalian host has developed a long-standing symbiotic relationship with a considerable number of microbial species. These include the microbiota on environmental surfaces, such as the respiratory and gastrointestinal tracts 1 , and also endogenous retroviruses (ERVs), comprising a substantial fraction of the mammalian genome 2,3 . The long-term consequences for the host of interactions with these microbial species can range from mutualism to parasitism and are not always completely understood. The potential effect of one microbial symbiont on another is even less clear. Here we study the control of ERVs in the commonly used C57BL/6 (B6) mouse strain, which lacks endogenous murine leukaemia viruses (MLVs) able to replicate in murine cells. We demonstrate the spontaneous emergence of fully infectious ecotropic 4 MLV in B6 mice with a range of distinct immune deficiencies affecting antibody production. These recombinant retroviruses establish infection of immunodeficient mouse colonies, and ultimately result in retrovirus-induced lymphomas. Notably, ERV activation in immunodeficient mice is prevented in husbandry conditions associated with reduced or absent intestinal microbiota. Our results shed light onto a previously unappreciated role for immunity in the control of ERVs and provide a potential mechanistic link between immune activation by microbial triggers and a range of pathologies associated with ERVs, including cancer.
The mammalian host has developed a long-standing symbiotic relationship with a considerable number of microbial species. These include the microbiota on environmental surfaces, such as the respiratory and gastrointestinal tracts 1 , and also endogenous retroviruses (ERVs), comprising a substantial fraction of the mammalian genome 2, 3 . The long-term consequences for the host of interactions with these microbial species can range from mutualism to parasitism and are not always completely understood. The potential effect of one microbial symbiont on another is even less clear. Here we study the control of ERVs in the commonly used C57BL/6 (B6) mouse strain, which lacks endogenous murine leukaemia viruses (MLVs) able to replicate in murine cells. We demonstrate the spontaneous emergence of fully infectious ecotropic 4 MLV in B6 mice with a range of distinct immune deficiencies affecting antibody production. These recombinant retroviruses establish infection of immunodeficient mouse colonies, and ultimately result in retrovirus-induced lymphomas. Notably, ERV activation in immunodeficient mice is prevented in husbandry conditions associated with reduced or absent intestinal microbiota. Our results shed light onto a previously unappreciated role for immunity in the control of ERVs and provide a potential mechanistic link between immune activation by microbial triggers and a range of pathologies associated with ERVs, including cancer.
Retroviruses can establish germline infection and become part of the host genome 2, 3 . Most, if not all, ERVs have become inactive owing to mutations, or transcriptionally silenced through the action of diverse mechanisms 2, 3 . However, RNA and protein expression of replicationdefective ERVs are frequently increased in infection, autoimmunity and cancer 2, 3 . Whether or not the immune system defends against potential threats posed by ERVs is unclear. To address the role of adaptive immunity in this process, we assessed ERV expression in B6 mice. We initially compared the transcriptional profiles of purified macrophages from B6 wild-type and T-and B-cell-deficient Rag1 2/2 mice. The two transcripts with the highest increase in expression levels in macrophages from Rag1 2/2 mice (Fig. 1a ) correspond to the env and gag genes, respectively ( Supplementary Table 1 ), of an endogenous ecotropic MLV (eMLV) locus, Emv2, a replication-defective single-copy ERV present in B6 mice 5 . Differential expression of eMLV was confirmed by quantitative reverse transcriptase PCR (qRT-PCR) for spliced env messenger RNA in macrophages ( Fig. 1b ) and in several tissues (Fig. 1c ).
Other ERV families were also differentially expressed in macrophages, albeit less strongly (1.7-2.1-fold; Supplementary Table 1 ). Not distinguishing between members of multicopy families, expression of polytropic MLVs (pMLVs), xenotropic MLVs (xMLVs) and the Mus musculus type D (MusD) retrovirus family of retrotransposons was also increased in the lungs of Rag1 2/2 mice ( Supplementary  Fig. 1 ). In line with increased MLV mRNA expression, 60-80% of total splenocytes and all haematopoietic lineages analysed from Rag1 2/2 but not wild-type mice, expressed MLV surface glycoprotein (SU) (Fig. 1d, e ). Tcra 2/2 or Tcrd 2/2 mice, lacking T-cell receptor (TCR)ab and TCRcd T cells, respectively, showed low eMLV expression ( Fig. 1f ). eMLV expression was similarly low in H2-A,E 2/2 mice (MGI allele upregulated (.4-fold) genes in CD11b 1 MHC-II hi B220 2 Gr1 2 macrophages from Rag1 2/2 mice compared with macrophages from wild-type (WT) mice. Triplicate microarrays from cells isolated from 40 mice are shown. b, eMLV spliced env mRNA expression in the same cells as in a. Each symbol represents macrophages from 20 mice (P 5 0.024; paired Student's t-test). c, eMLV spliced env mRNA expression in indicated organs from wild-type or Rag1 2/2 mice (spleen: P 5 0.020; ileum: P 5 0.032; colon: P 5 0.004; lung: P 5 0.001; muscle: P 5 0.016; and kidney: P 5 0.009; unpaired Student's t-test). d, e, MLV SU expression (detected using the 83A25 monoclonal antibody; see Methods) in splenocytes (d) or indicated cell types (e) from wild-type or Rag1 2/2 mice. f, eMLV spliced env mRNA expression in the spleens of the indicated strains (P , 0.001 between wild-type and either Ighm 2/2 or Ighm 2/2 MD4 mice; oneway analysis of variance (ANOVA)). g, MLV SU expression in splenic lymphocytes from wild-type or Ighm 2/2 MD4 mice. h, eMLV spliced env mRNA expression in the spleens of the indicated strains (P , 0.001 between wild-type and either Myd88 2/2 or Tlr7 2/2 mice; one-way ANOVA). In c, f and h, each symbol is an individual mouse. In d, e and g, plots are representative of four mice per group. In f and h, values above 10 3 were considered high and are indicated by red-filled symbols. H2 dlAb1-Ea ; lacking the region between the H2-Ab1 and H2-Ea genes), deficient in major histocompatibility complex (MHC) class II, MHC II-restricted T cells and T-cell-dependent antibodies (Fig. 1f ). By contrast, mice lacking B cells (Ighm 2/2 mice) or mice unable to produce polyclonal antibodies (Ighm 2/2 MD4 mice) expressed substantially higher eMLV levels than did wild-type mice ( Fig. 1f ), demonstrating that high eMLV expression characterized mice lacking antigen-specific antibodies. In addition to splenocytes from Rag1 2/2 mice ( Fig. 1e ), T and B cells from Ighm 2/2 MD4 mice, but not from wildtype control mice, expressed MLV SU ( Fig. 1g ), indicating that eMLV can also be highly expressed in lymphocytes. Toll-like receptors (TLRs) have been implicated in the control of B-cell responses, and Myd88 2/2 and Tlr7 2/2 mice have significantly reduced serum levels of natural antibodies and a defective antibody response to immunization or infection, including with retroviruses [6] [7] [8] [9] . Notably, the expression of eMLV was markedly increased in Myd88 2/2 and Tlr7 2/2 mice in comparison with wild-type mice ( Fig. 1h ). Similarly increased eMLV expression was observed in Tlr7 2/2 mice, but not in Tlr9 2/2 mice housed in a different facility ( Supplementary Fig. 2 ).
To investigate the mechanistic link between antibody deficiencies and increased MLV expression, we examined the origin of eMLV transcription. The B6 genome does not contain replication-competent eMLV proviruses, and, although the Emv2 locus can produce mRNA, it is unable to produce infectious virus owing to an inactivating G-to-C mutation at position 3576 of the pol region 5, 10 . In addition, Emv2 gag encodes an N-tropic capsid, which would be restricted by the Fv1 b restriction factor in B6 mice 10 . However, it was theoretically possible that recombination between replication-defective Emv2 and nonecotropic MLVs resulted in an MLV with full infectivity 11 that could spread in Rag1 2/2 mice. Remarkably, the plasmas of young and old Rag1 2/2 mice, but not of wild-type control mice, contained retroviruses that were capable of replicating in mouse cells in vitro ( Fig. 2a ), which we refer to as Rag1 2/2 mouse-associated retroviruses (RARVs). Sequencing of the pol region demonstrated repair of the Emv2inactivating mutation in all RARV isolates ( Supplementary Fig. 3 ). Functional in vitro assays ( Fig. 2b ) and sequencing of the gag region ( Fig. 2c ) showed that RARVs also exhibited B-tropism. Genome sequence comparisons between RARVs showed that young Rag1 2/2 mice contained highly similar viruses, which diverged substantially in old Rag1 2/2 mice ( Fig. 2d ). All RARVs were recombinants between Emv2 and endogenous non-ecotropic MLVs ( Supplementary Fig. 4 ). The pol defect of Emv2 was probably restored in RARVs by recombination with Xmv43 (also known as Bxv1; Supplementary Fig. 4 ), an ERV that contains a functional pol region but is unable to infect mouse cells owing to polymorphisms in the mouse cellular receptor 2 . Recombination events involving Xmv43 have also been found to be responsible for the emergence of leukaemogenic MLVs in AKR mice 12 . However, the switch in capsid tropism resulted from recombination with other endogenous xMLVs ( Supplementary Fig. 4 ). Notably, the divergence of RARVs isolated from old Rag1 2/2 mice was due to further recombination replacing the ecotropic env with polytropic env from Pmv1, Pmv5 or Pmv16 ( Supplementary Fig. 4 ). Together, these findings indicate the emergence of infectious eMLVs that could have infected Rag1 2/2 mice and given further rise to infectious pMLVs. Supporting this notion, most gag/pol eMLV mRNA detected in Rag1 2/2 mice seemed to be transcribed from integrated RARVs, rather than the germline copy of Emv2 ( Supplementary Fig. 5 ).
Emv2 and non-ecotropic MLV recombination events resulting in infectious eMLV generation might occur de novo in individual Rag1 2/2 mice. Alternatively, these RARVs might have been vertically transmitted through successive generations. To test the latter possibility directly and assess the capacity of RARVs to spread in immunodeficient mice, we established a colony of Rag1 2/2 Emv2 2/2 mice by first crossing an Emv2 2/2 male mouse 13 with a Rag1 2/2 female mouse, and then intercrossing selected progeny to homozygosity. These mice lack the germline copy of Emv2, meaning any infectious eMLV present would have been vertically transmitted. Both eMLV spliced env mRNA ( Fig. 2e ) and MLV SU expression ( Fig. 2f ) were readily detected in the spleens of Rag1 2/2 Emv2 2/2 mice in this colony. Furthermore, analysis of eMLV env and pol DNA copies indicated extensive replication of vertically transmitted RARVs in Rag1 2/2 Emv2 2/2 mice ( Fig. 2g ). e, eMLV spliced env mRNA expression in the spleens of Rag1 2/2 mice or vertically infected Rag1 2/2 Emv2 2/2 mice. Each dot is an individual mouse (P , 0.001; unpaired Student's t-test). Values above 10 3 were considered high and are indicated by red-filled symbols. f, MLV SU expression in splenocytes from Rag1 2/2 or vertically infected Rag1 2/2 Emv2 2/2 mice (representative of nine mice per group). g, eMLV DNA copy numbers per haploid genome, determined by qPCR for the pol or ecotropic env gene, in DNA from the spleens of healthy Rag1 2/2 mice (right) or vertically infected Rag1 2/2 Emv2 2/2 mice (left). Symbols represent individual mice, grouped according to their age. The sensitivity limit of this PCR method was determined as a median of 0.0003 copies per haploid genome, using Emv2 2/2 mice. eMLV DNA copy numbers for Rag1 2/2 mice include Emv2 (1/N). h, Tumour (leukaemias/lymphomas) incidence in cohorts of wild-type (n 5 37), Rag1 2/2 (n 5 38) or vertically infected Rag1 2/2 Emv2 2/2 mice (n 5 23) at the NIMR SPF facility (P , 0.000001 between wild-type and Rag1 2/2 mice; P 5 0.00025 between wild-type and Rag1 2/2 Emv2 2/2 mice; log-rank survival analysis).
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By contrast, sexual or in utero infection was not observed in separate crosses of either male or female virus-positive Rag1 2/2 Emv2 2/2 mice with virus-free Emv2 2/2 mice ( Supplementary Fig. 6 ).
To examine the potential of RARVs to replicate in Rag1 2/2 mice further, we assessed the frequency of tumours characteristic of retroviral infection 2,3 in cohorts of Rag1 2/2 mice. Notably, starting from 180 days and affecting 67% of the animals by 380 days, Rag1 2/2 mice, but not wild-type control mice, showed signs of morbidity ( Fig. 2h ). On examination, large tumours, often associated with anaemia, were observed in all morbid Rag1 2/2 mice ( Fig. 2h and Supplementary  Fig. 7 ). The pathogenic potential of infection with RARVs was established in aged cohorts of vertically infected Rag1 2/2 Emv2 2/2 mice, which developed tumours at a comparable incidence rate ( Fig. 2h ).
Thymic or splenic tumours in Rag1 2/2 mice consisted mainly of a single MLV SU-expressing cell type, which differed between animals, and had the histological appearance of lymphoblastic lymphosarcomas ( Supplementary Fig. 8 ). Discrete chromosomal aberrations were found in most tumours analysed ( Supplementary Fig. 8 ), suggestive of clonal origin. Consistent with MLV production by tumour cells, we observed an abundance of MLV-type particles in the extracellular space of tumour samples, but not in a spleen sample from a healthy Rag1 2/2 mouse ( Supplementary Fig. 9 ). Furthermore, a substantial increase in both eMLV env and pol DNA copy numbers was detected in all tumour samples, with one exception in which only pol DNA copies were increased ( Supplementary Fig. 9 ), indicating that RARVs had extensively infected the cells that gave rise to lymphomas. Together, these results support a model in which several recombination events restore Emv2 infectivity, leading to spontaneous retroviraemia and vertical transmission to progeny, and eventually drive an oncogenic process similar to that extensively described in mouse strains carrying fully infectious ERVs 2,3 .
Our results associated a lack of antibodies with establishment of infectious eMLVs in mouse colonies. Next, we investigated the potential mode of antibody action. Antiretroviral antibodies have a long-established role in limiting the spread of infectious endogenous retroviruses 14 , both within and between animals. However, it was also possible that antibodies were preventing a step before the emergence of infectious eMLV recombinants. Rescue of Emv2 infectivity by recombination with a nonecotropic MLV necessitates co-expression of both proviruses in the same cell at sufficient levels for co-packaging into the same virion. Low expression of these proviruses in wild-type mice could be a rate-limiting factor in the emergence of infectious eMLVs. However, expression of certain endogenous MLVs in mouse cells is known to be inducible, notably, by microbial products 2, 3, 15 . For example, bacterial lipopolysaccharide (LPS) stimulation activates non-ecotropic MLVs, and Xmv43 in particular [15] [16] [17] [18] [19] . To examine the responsiveness of ERVs and other retroelements to microbial stimulation, we took advantage of probes or probe sets in standard microarray platforms that report ERV or retroelement expression. Analysis of a publicly available data set 20 uncovered specific induction of non-ecotropic MLV transcripts by LPS and polyinosinic:polycytidylic acid (poly(I:C)), and suppression by Pam 3 CSK 4 (Fig. 3a, b ). Early transposon transcripts were also induced by poly(I:C) ( Fig. 3a) . These findings were confirmed by LPS stimulation, which induced high MLV SU expression in wild-type and Emv2 2/2 mouse splenocytes, also in a MyD88independent manner ( Fig. 3c and Supplementary Fig. 10 ). These in vitro conditions did not significantly induce eMLV expression ( Fig. 3a) . However, ex vivo analysis showed higher expression of eMLV ( Fig. 1c) , as well as of other ERVs/retroelements ( Supplementary Fig. 1 ), specifically in the colon, suggestive of microbial involvement.
Antibodies have established roles in controlling intestinal bacteria and neutralizing their products, such as LPS, in the gut lumen or the systemic circulation, and antibody-deficient mice are known to display increased microbial trasnslocation 1, 9, [21] [22] [23] . It was, therefore, possible that antibody deficiency allowed microbial products to induce expression of MLV proviruses in Rag1 2/2 mice, including the parents of recombinant RARVs ( Supplementary Fig. 1 ). In support of this notion, and in agreement with the established role of natural IgM in systemic clearance of bacterial LPS and protection from endotoxaemia 9, 21, 22 , production of non-hypermutated IgM alone was sufficient for eMLV control ( Supplementary Fig. 11 ). If antibodies required for preventing MLV expression were, indeed, against several microbial products, then antibody deficiency should not result in increased MLV expression in the absence of microbial triggers (Supplementary Fig. 12 ).
To begin to examine the contribution of microbial triggers, we measured eMLV expression in specific pathogen-free (SPF) Rag1 2/2 mice from colonies that differed in intestinal microbiota. Importantly, the use of embryo transfer for the rederivation of these independent colonies removes adventitious organisms, including vertically transmitted eMLVs. Therefore, any RARVs found in these rederived Rag1 2/2 mouse colonies must be generated de novo in the life-history of each colony. In stark contrast to Rag1 2/2 mice that were maintained on neutral pH water at the National Institute for Medical Research (NIMR), colonies of Rag1 2/2 mice that were maintained on acidified water expressed minimal eMLV levels (Fig. 4a ). Water acidification reduced overall bacterial diversity in the colons of Rag1 2/2 mice ( Supplementary Fig. 13 and Supplementary Table 2 ) and is a common precautionary measure used in many animal facilities that reduces bacterial colonization within the intestinal tract and translocation into the circulation 24 . Lack of eMLV expression was noted in Rag1 2/2 mice obtained from the Jackson Laboratory (JAX), also maintained on acidified water (Fig. 4a ). Furthermore, minimal levels of eMLV were detected in Rag1 2/2 mice on neutral pH water at the Rodent Center Table 3 ) signals in a publicly available Affymetrix HT mouse genome 430A microarray data set 20 (ArrayExpress accession E-GEOD-17721) of wild-type B6 bone marrowderived dendritic cells after stimulation with microbial products. Black arrows indicate the probe sets that are significantly regulated (P , 0.05) more than twofold by at least one stimulus. Emv2-specific probe sets (annotated as Mela) are also indicated by grey arrows for comparison. ETn, early transposon. b, Mean log 2 fold change in the MLV-reporting probe set in the same data set. c, MLV SU expression in wild-type or Emv2 2/2 splenocytes before (open histograms) or after (filled histograms) stimulation with 10 mg ml 21 LPS for 48 h, according to forward scatter (Fsc) and CD19 expression. Numbers in the plots denote the percentage of cells within each gate and represent two donors each analysed in duplicate.
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HCI (RCHCI; Fig. 4a ), which contained distinct bacterial genera in comparison with Rag1 2/2 mice at NIMR ( Supplementary Fig. 13 and Supplementary Table 2 ). Lastly, negligible levels of eMLV were expressed in Rag1 2/2 mice in germ-free facilities at the University of Michigan (UMICH) and offered neutral pH water (Fig. 4a ). The latter two conditions also distinguished between effects of acidified water on intestinal flora and effects on other physiological processes. Thus, high eMLV expression in independently rederived colonies of Rag1 2/2 mice correlated with the presence of the normal SPF microbiota.
Husbandry conditions contributed to high eMLV expression also in independently rederived strains with distinct immunodeficiencies. Colonies of Ighm 2/2 and Tlr7 2/2 mice maintained on acidified water at JAX expressed minimal levels of eMLV ( Fig. 4b ). Variable eMLV expression levels were detected in Myd88 2/2 mice at JAX (Fig. 4b ), probably because, once generated, vertical transmission of infectious eMLVs was unaffected by water acidification. Although defining the precise role of the microbiota on eMLV induction will require further investigation, collectively our results demonstrate that the high eMLV expression phenotype, in genotypes causing immunodeficiency, requires environmental interaction.
High eMLV expression in independently rederived immunodeficient colonies reveals de novo eMLV induction in each colony. It does not, however, indicate when or how often in the life-history of a colony infectious eMLVs may emerge. Adult RARV-free Rag1 2/2 mice, previously on acidified water, maintained low eMLV expression after a switch to neutral pH water, indicating a low probability of RARV emergence and spread in an individual mouse. To examine whether this probability is low in general or could be higher during early mouse development, we monitored successive generations of Ighm 2/2 mouse colonies from two independent rederivations, one of which was recent, into the NIMR SPF facility. This analysis suggested that eMLV induction occurred during the first few filial generations (F; Supplementary  Fig. 14) . Moreover, eMLV-expressing Myd88 2/2 mice at JAX (Fig. 4b ), were at F 5 of homozygous breeding. Thus, although low in individual mice, there is high cumulative probability of infectious eMLV emergence, involving a sequence of recombination events similar to those seen in Rag1 2/2 mice ( Supplementary Fig. 12 ), and subsequent establishment in an antibody-deficient colony over a few generations.
The B6 strain has historically dominated many research fields, partly owing to the resistance of this strain to retrovirally induced tumours. Our results demonstrate that this important attribute of B6 mice is conditional on their immune competence, with significant implications both for the design and interpretation of mouse studies. Furthermore, our results show that ERV activation is determined by husbandry conditions, thus accentuating potential differences in ERV expression between animal facilities.
Although well-established in the mouse 2,3 , the oncogenic potential of ERVs in humans has not been observed 25, 26 . However, non-long terminal repeat (LTR) retroelement families have been documented to have caused human cancers by insertional mutagenesis at the somatic level 25, 26 . Interestingly, we found that TLR stimulation of human cells induced expression of distinct ERVs and retroelements, including the mammalian apparent LTR retrotransposon (MaLR) family ( Supplementary Fig. 15 ), previously implicated in the pathogenesis of human lymphomas 27 . Transcription of human ERVs and retroelements can also be induced by physiological activation of both adaptive and innate immune cells 28 . Moreover, increased risk of lymphomas in humans is linked to infection or inflammation 29 and also to antibody deficiencies 30 . Thus, interactions between microbial symbionts, leading to ERV/retroelement activation, may provide a mechanistic link between cancer and stimulation of the immune system by microbiota or pathogenic infections.
METHODS SUMMARY
Mice. Inbred C57BL/6J (B6) or genetically modified B6-backcrossed mice were from the following facilities: NIMR (London, UK); JAX (Massachusetts, USA); UMICH (Michigan, USA); CIML (Marseille, France); London Research Institute, Cancer Research UK (London, UK); RCHCI (Zürich, Switzerland); or Center for Cancer Research, National Cancer Institute (Maryland, USA). Mice were kept in individually ventilated cages in SPF facilities or in germ-free isolators. Mice were maintained on either neutral pH or acidified water. Where indicated, colonies were established by rederivation into each of these facilities. This process ensures the removal of adventitious agents and leads to colonization of the newly rederived mice with the specific microbiota of each facility (or the lack of colonization in the case of the germ-free facility). All animal experiments were approved by ethical committees of respective institutes, and conducted according to local guidelines and regulations. 38 , and toll-like receptor adaptor molecule 1 (TICAM-1)-deficient B6.129P2-Ticam1 tm1Aki (Ticam1 2/2 ) mice 39 have been described. B6-congenic mice lacking Emv2 (Emv2 2/2 ) were generated by 12 nuclear generations onto the B6 genetic background of the respective site on chromosome 8 from the A/J strain, which lacks the Emv2 integration, and have been previously described 40 . Emv2 2/2 mice were subsequently crossed with B6-backcrossed Rag1 2/2 mice to create Rag1 2/2 Emv2 2/2 mice. These strains were maintained in individually ventilated cages (IVCs) in SPF facilities at the NIMR, and kept on ultravioletirradiated and filtered neutral pH water. In addition, separate colonies of Rag1 2/2 , Ighm 2/2 , Myd88 2/2 , Tirap 2/2 and Tcam1 2/2 mice were maintained in the same facilities and constantly kept on a diet of acidified water (pH 2.5). B6 and B6-backcrossed B6.129S7-Rag1 tm1Mom /J (Rag1 2/2 ) mice, B6.129S2-Ighm tm1Cgn /J (Ighm 2/2 ) mice, B6.129S1-Tlr7 tm1Flv /J (Tlr7 2/2 ) mice 41 , and B6.129P2-Myd88 tm1.1Defr /J (Myd88 2/2 ) mice 42 were also maintained in SPF facilities at the Jackson Laboratory, and were kept on acidified water (pH 2.8-3.2).
B6 and B6-backcrossed B6.129S7-Rag1 tm1Mom (Rag1 2/2 ) were also maintained in germ-free facilities at the UMICH, and kept on autoclaved distilled water.
B6 and B6-backcrossed B6.129S1-Tlr7 tm1Flv (Tlr7 2/2 ) mice, and B6.129P2-Tlr9 tm1Aki (Tlr9 2/2 ) mice 43 were also maintained in SPF facilities at the Centre d'Immunologie de Marseille-Luminy (CIML), and kept on autoclaved water.
B6-backcrossed TLR7-deficient B6.129P2-Tlr7 tm1Aki (Tlr7 2/2 ) mice 44 were also maintained in SPF facilities at the London Research Institute (LRI), Cancer Research UK, and kept on autoclaved water. These mice were received into the NIMR quarantine facility and bred before testing.
B6 and B6-backcrossed B6.129S7-Rag1 tm1Mom (Rag1 2/2 ) mice, B cell-deficient, Ig heavy chain joining region-targeted B6.129S7-Igh-J tm1Dhu (Igh-J 2/2 ) mice 45 , IgA-deficient, Ig heavy constant a chain-targeted B6.129S7-Igha tm1Grh (Igha 2/2 ) mice 46 , and polymeric Ig receptor-deficient B6.129P2-Pigr tm1Rast (Pigr 2/2 ) mice 47 were maintained in individually ventilated cages in SPF facilities at RCHCI and kept on autoclaved water. C57BL/6NCrl-backcrossed B6.129S2-Ighm tm1Cgn (Ighm 2/2 ) and activationinduced cytidine deaminase-deficient B6.CBA-Aicda tm1Hon (Aicda 2/2 ) mice 48 , were also maintained in SPF facilities at the Center for Cancer Research, National Cancer Institute, and kept on autoclaved water.
All colonies of Rag1 2/2 mice tested in this study (NIMR, JAX, UMICH and RCHCI) were established by rederivation of a common JAX stock into each of these facilities. This process ensures the removal of adventitious agents, including infectious eMLVs, and leads to colonization of the newly rederived mice with the specific microbiota of each facility (or the lack of colonization in the case of the germ-free facility). These independent colonies were maintained by homozygous breeding for at least 12 and up to 45 filial generations (F 12 -F 45 ) before testing.
Colonies of Ighm 2/2 mice at NIMR and JAX were also established by rederivation. The Ighm 2/2 mouse colony at JAX was at least the F 15 of homozygous breeding before testing. Two colonies of Ighm 2/2 mice, established at NIMR by two independent rederivations (as part of the unit reorganization), were tested at different points after rederivation. The first was maintained for 16 months (F 4 ) on a diet of neutral pH water (before switching to acidified water for F 12 ), and the second, more recent colony was maintained on a diet of neutral pH water for only 7 months (F 1 -F 2 ) before testing.
Colonies of Myd88 2/2 mice at NIMR and JAX were also established by rederivation and maintained for approximately F 16 and F 5 of homozygous breeding, respectively, before testing. Colonies of Tlr7 2/2 mice at LRI/NIMR, JAX and CIML were also established by rederivation and maintained for approximately F 11 , F 5 and F 9 of homozygous breeding, respectively, before testing.
Unless otherwise indicated (for example, aged mice) all mice were used between 4 and 8 weeks after birth. All animal experiments were approved by ethical committees of respective institutes, and conducted according to local guidelines and regulations. Expression analyses. For transcriptional analysis, peritoneal exudate cells were isolated from B6 or Rag1 2/2 mice and were subsequently purified by cell sorting, performed on MoFlo cell sorters (Dako), as CD11b 1 MHC-II hi B220 2 Gr1 2 macrophages. RNA was isolated from the cells using TRI reagent (Sigma-Aldrich), according to manufacturer's instructions. Purified RNA samples were checked for quality using the Agilent bioanalyzer (Agilent). Synthesis of cDNA, probe labelling and hybridization were performed using Affymetrix MouseGene 1.0 ST oligonucleotide arrays. Primary microarray data from triplicate arrays were analysed with GeneSpring GX (Agilent Technologies).
ERV/retroelement transcription was quantified in various tissues by qRT-PCR. In brief, organs were removed from mice and placed in TRI reagent or RNAlater (Invitrogen) at each animal facility. For mice bred outside the NIMR, tissues were then shipped to the NIMR for further processing. Total RNA was isolated with TRI reagent, precipitated with isopropanol and washed in 75% ethanol before being dissolved in water. DNase digestion and clean-up was performed with the RNeasy mini kit (Qiagen) and cDNA produced with the High Capacity reverse transcription kit (Applied Biosystems) with an added RNase inhibitor (Promega Biosciences). A final clean-up was performed with the QIAquick PCR purification kit (Qiagen). RNase-free water (Qiagen) and later nuclease-free water (Qiagen) were used throughout the protocol. Purified cDNA was then used as a template for the amplification of target gene transcripts with SYBR Green PCR Master Mix (Applied Biosystems), run on the ABI Prism SDS 7000 and 7900HT (Applied Biosystems) cyclers, with the following primers (produced by Eurofins MWG Operon). eMLV spliced env cDNA (116base pair (bp) product; primers previously described 40 Primers specific for pMLV, modified pMLV, xMLV, MusD retrovirus, mouse retroviruses that use tRNA Gln (GLN), murine endogenous retrovirus-like and intracisternal A-type particle elements have been previously described [49] [50] [51] . Data are plotted as expression of the target transcript, relative to expression of Hprt in the same sample, derived using the algorithm:
Value 5 2 (CT value of Hprt 2 CT value of target) 3 10 4 .
A theoretical detection limit of two arbitrary units is also shown as dashed horizontal lines. For eMLV expression in particular, values above 10 3 were considered as high and are indicated with red-filled symbols.
eMLV mRNA transcripts originating from the Emv2 locus or from potentially integrated RARV proviruses were distinguished by RT-PCR on cDNA reversetranscribed using a reverse primer specific to the ecotropic env gene (59-TT CTGGACCACCACACGAC-39) and amplified using unique transcript-specific forward primers in the pol region together with a common reverse primer in the same region. The 39 nucleotides of the transcript-specific forward primers correspond to position 3576 of the pol gene, which is a C in Emv2, but a required G in all sequenced RARVs. The following primers (produced by Eurofins MWG Operon) were used. Emv2 specific mRNA: forward, 59-CCTGGGTTTGCGGAAATGG CAC-39. RARV specific mRNA, forward, 59-CCTGGGTTTGCGGAAATGGC GG-39; reverse, 59-TTTGGCGTAGCCCTGCTTCTCG-39. Both PCRs produce a 192-bp product. Microarray-based analyses of retroelement expression. Expression levels of ERVs and retroelements were determined in publicly available microarray data sets, by assigning ERV-or retroelement-reporting probes to the correct ERV or retroelement family they are reporting. Individual probe sequences were obtained for mouse and human microarray platforms from the vendors' websites. Nucleotide sequence data for mouse and human retroelements (including elements present in ancestral species) were downloaded from RepBase Update 52 (http://www.girinst.org/repbase; v25/11/2011) and further human retroelements from dbRIP database 53 (http://www.dbrip.org; v2h). Low-copy mouse ERV sequences were obtained from the literature 54, 55 , database searches and mining of the C57BL/6J RefSeq assembly (v37) sequence. Local BLAST libraries were produced with the NCBI C11 Toolkit (http://blast.ncbi.nlm.nih.gov/) and a Python 3.2 (http://www.python.org/) script was used to run and query BLASTn ('-task blastn-short' optimized) for the obtained probe sequences. Three separate stringencies were used in the screening: 90% (.90% length, .90% nucleotide homology), 95% (.95% length, .95% nucleotide homology) and 100% (identical matching required). For microarray platforms in which single transcripts are represented by several probes, a further screen was imposed to ensure .75% of probes gave appropriate BLASTn hits. Under this threshold, probes were assumed to be divided across a retroelement-gene boundary and were excluded from further analysis. Probes were compiled from the 90% stringency analysis for human and mouse retroelements and from the 100% stringency analysis for low-copy C57BL/6J ERVs. These were used to produce a Python tool, REquest, which will be described in detail elsewhere, and the code of which is available on request, to mine retroelement expression from text-based microarray analysis output. Emv2/eMLV copy number analysis. DNA copy numbers of Emv2/eMLV were determined by qPCR on DNA samples isolated from the indicated organs or tumours using the following primers (Eurofins MWG Operon). Emv2/eMLV LETTER RESEARCH env DNA (169-bp product; primers modified from published sequences 49 ): forward, 59-AGGCTGTTCCAGAGATTGTG-39; reverse, 59-TTCTGGACCACC ACACGAC-39. Emv2/eMLV pol DNA (76-bp product; primers previously described 56 ): forward, 59-CACTTTGAGGGATCAGGAGCC-39; reverse, 59-CT TCTAGGTTTAGGGTCAACACCTGT-39.
Signals were normalized for the amount of DNA used in the reactions based on amplification of the single-copy Ifnar1 gene with the following primers. Ifnar1 DNA (150-bp product): forward, 59-AAGATGTGCTGTTCCCTTCCTCTGCT CTGA-39; reverse, 59-ATTATTAAAAGAAAAGACGAGGCGAAGTGG-39.
Copy numbers were calculated with a DDC T method, using splenic DNA from B6 mice as control, which was assigned a value of 1 copy per haploid (N) genome. Sequencing and sequence analyses. Bacterial general diversity was determined in faecal samples from the colons of mice, by high-throughput sequencing of amplicons of bacterial DNA encoding 16S ribosomal RNA, using a the Roche FLX genome sequencer. Samples were collected at either NIMR or RCHCI, and were subsequently transported frozen to NIMR, where DNA was isolated, using the QIAamp DNA stool mini kit (Qiagen). DNA amplification, sequencing and metagenomic analysis was performed by DNAVision.
The region of the pol gene carrying the inactivating mutation in Emv2 was sequenced in isolated RARVs as described later. A 708-bp fragment spanning this region was amplified from genomic DNA isolated from Mus dunni cells infected with the respective RARV using the following primers (Eurofins MWG Operon). Emv2/eMLV pol DNA (708-bp product): forward, 59-ATCGGGCCTCGGCCA AGAAAG-39; reverse, 59-CCGGGAGAGGGAGTAAGGTGGC-39. RARV genomes were amplified from the same DNA template in two halves using the following primers (Eurofins MWG Operon). RARV first half (4,074-bp product): forward, 59-GCGCCAGTCCTCCGATAGACT-39; reverse, 59-CCGGGAGAG GGAGTAAGGTGGC-39. RARV second half (4,909-bp product): forward, 59-ATCGGGCCTCGGCCAAGAAAG-39; reverse, 59-TGCAACAGCAAAAGGCT TTATTGG-39.
PCR products were purified with the QIAquick PCR purification kit (Qiagen) and subjected to sequencing at Source BioScience (Cambridge, UK).
Sequence analyses, comparisons and alignments were performed with Vector NTI v11.5 (Invitrogen). RARV contigs were aligned against B6 MLVs as previously defined 54 using MAFFT within UGENE software 57, 58 . Distance plots were calculated with RDP (Recombination Detection Program) v4.16, using a 100 bp window and a 10 bp shift 58 . RARV phylogenetic analyses were performed with PHYLIP (Phylogeny inference package) v3.2 within UGENE software. FACS. Cell suspensions from spleens, lymph nodes or peritoneal exudates were stained with directly conjugated antibodies to surface markers, obtained from eBiosciences, CALTAG/Invitrogen, BD Biosciences or BioLegend. MLV SU was detected using the 83A25 monoclonal antibody 59 (rat IgG2a, anti-MLV SU) as the primary reagent, followed by staining with a biotinylated anti-rat IgG2a antibody (clone RG7/1.30, BD Biosciences) as the secondary reagent, and a streptavidinphycoerythrin (PE) conjugate (BioLegend) or a streptavidin-PE Texas Red conjugate (CALTAG/Invitrogen) as the tertiary reagent. Four-and eight-colour cytometry was performed on FACSCalibur (BD Biosciences) and CyAn (Dako) flow cytometers, respectively, and analysed with FlowJo v8.7 (Tree Star Inc.) or Summit v4.3 (Dako) analysis software, respectively. Retroviral isolation and assays. For the isolation of infectious MLVs plasma samples obtained from Rag1 2/2 mice were incubated with M. dunni cells transduced with the XG7 replication-defective retroviral vector, expressing GFP from a human cytomegalovirus promoter and a neomycin-resistance gene under the control of the LTR 60 . The presence of infectious MLVs was examined after 10-14 days of culture by testing for the presence of pseudotyped XG7 vector in culture supernatant. For this, culture supernatant of XG7-transduced M. dunni cells that had been incubated with plasma samples was subsequently added onto untransduced M. dunni cells, which were then assessed for GFP expression by flow cytometry 3 days later. The Fv1 tropism of infectious MLVs was determined by adding serial dilutions of culture supernatant of XG7-transduced M. dunni cells that had been incubated with plasma samples onto B-3T3 or N-3T3 cells. Infection was quantified by GFP expression in these cells 3 days later. B-tropic and N-tropic stocks of F-MLV, obtained as culture supernatant of M. dunni cells chronically infected with these viruses, were used as controls. Results were expressed as B:N ratios-the percentage of GFP 1 cells in B-3T3 cultures divided by the percentage of GFP 1 cells in N-3T3 cultures. Histology. For histological analysis, organs were collected in formalin immediately after culling of donor mice. Histological sections were prepared and stained with haematoxylin and eosin and assessed by M. Stidworthy. Transmission electron microscopy. Samples were immersion fixed in 2% glutaraldehyde/2% paraformaldehyde and post-fixed in 1% osmium tetroxide using 0.1 M sodium cacodylate buffer, pH 7.2. Aqueous uranyl acetate was followed by dehydration through a graded ethanol series and propylene oxide. Samples were then embedded in Epon and 50-nm sections mounted on pioloform coated grids and stained with ethanolic uranyl acetate followed by Reynold's lead citrate. They were viewed with a JEOL 100EX transmission electron microscope equipped with an ORIUS 1000 CCD camera (Gatan). Statistical analyses. Statistical comparisons were made using SigmaPlot 12.0 (Systat Software Inc.). Parametric comparisons of normally distributed values that satisfied the variance criteria were made by unpaired Student's t-tests. Pairwise comparisons of data sets that did not pass the variance test were compared with non-parametric two-tailed Mann-Whitney Rank Sum. Bacterial diversity was compared with ANOVA tests with Bonferroni correction for multiple comparisons. Tumour incidence rates were compared by log-rank survival analysis of Kaplan-Meier curves. ANOVA and statistical comparisons of microarray data were made using GeneSpring GX, with Benjamini-Hochberg false discovery rate correction for multiple comparisons.
